Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04667572
Other study ID # PXL-330-CAT-2
Secondary ID
Status Active, not recruiting
Phase Phase 1
First received
Last updated
Start date February 1, 2021
Est. completion date August 31, 2024

Study information

Verified date July 2023
Source Cornea Associates of Texas
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Collagen Cross-linking in Eyes With Corneal Thinning Conditions


Description:

Patients with progressive keratoconus, pellucid marginal degeneration, or at risk for post-refractive corneal ectasia will be recruited and undergo epithelial-on corneal crosslinking with the Peschke PXL-330 system using pulsed, accelerated energy delivery. Patients will undergo monitoring for 1 year, with serial measurements of corneal topography, visual acuity, pachymetry, and visual function.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 1000
Est. completion date August 31, 2024
Est. primary completion date August 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 8 Years and older
Eligibility Inclusion Criteria: - 8 years of age or older - Signed written informed consent - Willingness and ability to comply with schedule for follow-up visits - Contact Lens Wearers Only: - Removal of contact lenses (if applicable) for the required period of time prior to the screening refraction: Soft, discontinue 3 days; Soft Extended Wear, discontinue 3 days; Soft Toric, discontinue 3 days; Rigid gas permeable, discontinue 2 Weeks (subjects who cannot function without wearing their contact lenses, may forgo discontinuation of contact lenses) And one or more of the following: - Presence of central or inferior steepening. - Axial topography consistent with keratoconus, post-surgical ectasia, or pellucid marginal degeneration - Presence of one or more findings associated with keratoconus or pellucid marginal degeneration, such as: Fleischer ring, Vogt's striae, Decentered corneal apex, Munson's sign, Rizzutti's sign, Apical Corneal scarring consistent with Bowman's breaks, Scissoring of the retinoscopic reflex, Crab-claw appearance on topography - Steepest keratometry (Kmax) value = 47.20 D - I-S keratometry difference > 1.5 D on the Pentacam/Orbscan map or topography map - Posterior corneal elevation >16 microns - Thinnest corneal point >300 microns Exclusion Criteria: - Eyes classified as either normal or atypical normal on the severity grading scheme. - Corneal thickness < 300 microns measured by ultrasonic pachymetry or pentacam. - Previous ocular condition (other than refractive error) in the eye(s) to be treated that may predispose the eye for future complications, for example: History of or active corneal disease (e.g., herpes simplex, herpes zoster keratitis, recurrent erosion syndrome, etc.) Clinically significant corneal scarring in the CXL treatment zone that is not related to keratoconus or, in the investigator's opinion, will interfere with the cross-linking procedure. - Pregnancy (including plan to become pregnant) or lactation during the course of the study - A known sensitivity to study medications - Patients with nystagmus or any other condition that would prevent a steady gaze during the CXL treatment or other diagnostic tests. - Patients with a current condition that, in the physician's opinion, would interfere with or prolong epithelial healing

Study Design


Related Conditions & MeSH terms


Intervention

Combination Product:
PXL-330 Platinum device for crosslinking with Peschke riboflavin solution
Riboflavin will be used to load the cornea, followed by UV-A crosslinking of the cornea

Locations

Country Name City State
United States Cornea Associates of Texas Dallas Texas

Sponsors (1)

Lead Sponsor Collaborator
Cornea Associates of Texas

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary K-Max Change in K-Max measured by corneal topography, compared to baseline 12 Months
Primary K-Mean Change in K-Mean measured by corneal topography, compared to baseline 12 Months
Secondary Uncorrected Visual Acuity Change in uncorrected corrected visual acuity using snellen measurements, compared to baseline 12 Months
Secondary Best Corrected Visual Acuity Change in best corrected visual acuity using snellen measurements, compared to baseline 12 Months
Secondary Central Pachymetry Change in central pachymetry, measured by Pentacam compared to baseline 12 Months
See also
  Status Clinical Trial Phase
Recruiting NCT04570020 - Scleral Lens Fitting Using Wide-Field OCT
Recruiting NCT02921009 - McNeel Eye Center Corneal Crosslinking Study N/A
Completed NCT01691651 - Botulinum Toxin A for the Treatment of Keratoconus N/A
Terminated NCT02762253 - Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus. Phase 2
Completed NCT01527708 - Accuracy of Curvature and Wavefront Aberrations of Posterior Corneal Surface, in Keratoconic and Post-CXL Corneas N/A
Completed NCT01527721 - Blurring Strength & Aberrometric Changes Following Corneal Cross-linking (CxL) and CxL Combined With Photorefractive Keratectomy (PRK) in Keratoconus N/A
Recruiting NCT00841386 - Treatment of Keratoconus Using Collagen Cross-Linking Phase 2/Phase 3
Completed NCT00347074 - A Clinical Study of Keratoconus in Asian Patients and Assessment of Different Topographic Patterns of Keratoconus in Asian Patients N/A
Completed NCT03187912 - Accelerated Corneal Cross-linking With Different Riboflavin Solutions Phase 3
Completed NCT00584285 - Corneal Topographer Fluorescein Patterns
Completed NCT03511495 - Reliability of Topography Measurements in Keratoconus
Not yet recruiting NCT05395650 - Cyanocobalamin as Photosensitizing Agent
Completed NCT04418999 - Safety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With Keratoconus Early Phase 1
Completed NCT05019768 - Topo-pachimetric Accelerated Epi-On Cross-linking Compared to Dresden Protocol Using Riboflavin With Vitamin E TPGS N/A
Completed NCT03235856 - Retrospective Digital Computer Analysis of Keratoconus Evolution - REDCAKE
Withdrawn NCT01789333 - Higher Irradiance in Keratoconus Ectasia N/A
Completed NCT05114928 - Correlation Between Q-value Changes and Progression of Pediatric Keratoconus.
Completed NCT03647046 - Custom Anterior Surfacing of Scleral Lens for Vision Quality Improvement in Patients With Keratoconus N/A
Recruiting NCT04439552 - fMRI and IVCM Cornea Microscopy of CXL in Keratoconus
Recruiting NCT06100939 - Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus Phase 3